An individual with an orbital tumor should be evaluated and treated by an expert team at a major medical center, where a multidisciplinary tumor board works together to develop the optimal treatment plan. The doctors who may be involved in the treatment plan include neurosurgeons, ophthalmologists, otolaryngologists, oncologists, radiologists, and interventional neuroradiologists. At Weill Cornell Medicine Neurological Surgery, patients with orbital tumors may be seen by:
Philip E. Stieg, PhD, MD, the chair of Weill Cornell Medicine Neurological Surgery and neurosurgeon-in-chief of NewYork-Presbyterian/Weill Cornell Medical Center, leads the cerebrovascular team. Dr. Stieg is one of the top neurosurgeons in the nation, having been named one of America’s Top Doctors by Castle Connolly each year since that designation was created more than two decades ago. Dr. Stieg has developed an international reputation in the area of cerebrovascular disorders and surgery; his work has been broadly published, and he has contributed to groups such as the Joint Sections of Cerebrovascular Surgery of the American Association of Neurological Surgeons and Congress of Neurological Surgeons (AANS/CNS). He is the past President of the Society of University Neurosurgeons and has received multiple awards and honors for his work. (Read more about Dr. Stieg.)
Henry M. Spinelli, MD, is Clinical Professor of Surgery and Clinical Professor of Neurological Surgery at Weill Cornell Medical College and Attending Surgeon at New York-Presbyterian/Weill Cornell Medical Center. Dr. Spinelli has a unique background, with training and experience in ophthalmology as well as plastic and craniofacial surgery. He serves as Editor-in Chief of Aesthetic Plastic Surgery, the official journal of the International Society of Aesthetic Plastic Surgery. Dr. Spinelli has gained national and international recognition in the areas of craniofacial, orbital, oculoplastic, and aesthetic surgery. He continues to lecture, teach, and write extensively in these areas, including a single author text entitled: Atlas of Aesthetic Eyelid and Periocular Surgery. He and Dr. Stieg work closely on complex orbital tumor and skull base surgeries. (Read more about Dr. Spinelli.)
Y. Pierre Gobin, MD, is an internationally recognized expert with 20 years of experience in the treatment of vascular diseases of the brain and spine. A pioneer in endovascular treatment of cerebral aneurysms, Dr. Gobin has also been at the forefront of the new field of super-selective intra-arterial chemotherapy for retinoblastoma and other tumors. (Read more about Dr. Gobin.)
Rohan Ramakrishna, MD, is an award-winning neurosurgeon who specializes in the treatment of brain tumors and other central nervous system tumors. Dr. Ramakrishna treats patients with gliomas, metastatic disease, skull base lesions, and pituitary disorders. He employs advanced awake mapping, imaging techniques, and microsurgery to ensure maximal tumor removal and achieve the safest possible surgical outcomes. (Read more about Dr. Ramakrishna.)
Kyle Godfrey, MD, is an ophthalmologist who is board certified and fellowship trained in oculofacial plastic surgery, a sub-specialty focused on cosmetic, reconstructive, and tumor surgery of the eyelids, orbit (eye socket), lacrimal (tear drainage) system, eyebrows, and face. He works closely with Dr. Theodore Schwartz here at the main campus of NewYork-Presbyterian/Weill Cornell Medical Center as well as with Dr. Rohan Ramakrishna at NewYork-Presbyterian Brooklyn Methodist, in treating patients with orbital tumors. (Read more about Dr. Godfrey.)
The neurosurgeons at Weill Cornell Medicine Neurological Surgery are fortunate to be part of NewYork-Presbyterian, which is routinely named to lists of top hospitals in New York. Our Neurology and Neurosurgery program is best in New York, and we have the Best Outcomes for Kids in New York. Together, the NewYork-Presbyterian/Weill Cornell Medical Center team is the best choice for orbital tumor surgery and the treatment of retinoblastomas and other, related tumors.
